{
  "id": "73748b1584c7c98c",
  "title": "STAT+: GSK to buy RAPT Therapeutics, maker of food allergy treatment, in $2.2B deal",
  "description": "GSK is buying RAPT Therapeutics in a deal worth $2.2 billion, picking up an experimental medicine for food allergies.",
  "content": "GSK is buying RAPT Therapeutics in a deal worth $2.2 billion, picking up an experimental medicine for food allergies.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2026/01/20/gsk-rapt-therapeutics-acquisition-food-allergy-prophylaxis-ozureprubart/?utm_campaign=rss",
  "published_at": "2026-01-20T08:01:57+00:00",
  "fetched_at": "2026-01-21T00:24:36.527019+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [],
  "location": null,
  "raw_data": {
    "title": "STAT+: GSK to buy RAPT Therapeutics, maker of food allergy treatment, in $2.2B deal",
    "description": "GSK is buying RAPT Therapeutics in a deal worth $2.2 billion, picking up an experimental medicine for food allergies.",
    "url": "https://www.statnews.com/2026/01/20/gsk-rapt-therapeutics-acquisition-food-allergy-prophylaxis-ozureprubart/?utm_campaign=rss",
    "published": "2026-01-20T08:01:57+00:00",
    "source": "STAT"
  }
}